# Methotrexate in the Treatment of Chronic Idiopathic Urticaria

> **NCT01960283** · PHASE3 · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 83 (actual)

## Conditions studied

- Chronic Urticaria

## Interventions

- **DRUG:** Methotrexate (Novatrex ®) + anti-H1
- **DRUG:** Placebo + anti-H1

## Key facts

- **NCT ID:** NCT01960283
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-05
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2017-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01960283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01960283, "Methotrexate in the Treatment of Chronic Idiopathic Urticaria". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01960283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*